The role of lymphadenectomy for upper tract urothelial carcinoma

Jamie Messer, Yu Kuan Lin, Jay Raman

Research output: Contribution to journalReview article

9 Citations (Scopus)

Abstract

Regional lymphadenectomy, with both its diagnostic and therapeutic roles, serves as an integral component of the management of many malignancies. Extended pelvic lymph node dissection (LND) is the standard of care for urothelial carcinoma of the bladder, with the extent of lymphadenectomy correlating positively with cancer-related outcomes. Given their histologic similarities with bladder cancer, it is reasonable to hypothesize that a similar relationship exists for upper tract urothelial carcinomas (UTUCs). However, the data published to date have failed to consistently demonstrate a therapeutic benefit of regional LND for UTUC. As a consequence, utilization of regional lymphadenectomy remains at the discretion of the surgeon, the extent of LND lacks standardization, and its clinical utility continues to be debated. In order to better clarify the existing data, we present a review of the role of regional lymphadenectomy in patients with UTUC.

Original languageEnglish (US)
Pages (from-to)394-401
Number of pages8
JournalNature Reviews Urology
Volume8
Issue number7
DOIs
StatePublished - Jul 1 2011

Fingerprint

Lymph Node Excision
Carcinoma
Standard of Care
Urinary Bladder Neoplasms
Neoplasms
Urinary Bladder
Therapeutics

All Science Journal Classification (ASJC) codes

  • Urology

Cite this

Messer, Jamie ; Lin, Yu Kuan ; Raman, Jay. / The role of lymphadenectomy for upper tract urothelial carcinoma. In: Nature Reviews Urology. 2011 ; Vol. 8, No. 7. pp. 394-401.
@article{b87484ffb5d94cbabab9f2639f24e0c8,
title = "The role of lymphadenectomy for upper tract urothelial carcinoma",
abstract = "Regional lymphadenectomy, with both its diagnostic and therapeutic roles, serves as an integral component of the management of many malignancies. Extended pelvic lymph node dissection (LND) is the standard of care for urothelial carcinoma of the bladder, with the extent of lymphadenectomy correlating positively with cancer-related outcomes. Given their histologic similarities with bladder cancer, it is reasonable to hypothesize that a similar relationship exists for upper tract urothelial carcinomas (UTUCs). However, the data published to date have failed to consistently demonstrate a therapeutic benefit of regional LND for UTUC. As a consequence, utilization of regional lymphadenectomy remains at the discretion of the surgeon, the extent of LND lacks standardization, and its clinical utility continues to be debated. In order to better clarify the existing data, we present a review of the role of regional lymphadenectomy in patients with UTUC.",
author = "Jamie Messer and Lin, {Yu Kuan} and Jay Raman",
year = "2011",
month = "7",
day = "1",
doi = "10.1038/nrurol.2011.78",
language = "English (US)",
volume = "8",
pages = "394--401",
journal = "Nature Reviews Urology",
issn = "1759-4812",
publisher = "Nature Publishing Group",
number = "7",

}

The role of lymphadenectomy for upper tract urothelial carcinoma. / Messer, Jamie; Lin, Yu Kuan; Raman, Jay.

In: Nature Reviews Urology, Vol. 8, No. 7, 01.07.2011, p. 394-401.

Research output: Contribution to journalReview article

TY - JOUR

T1 - The role of lymphadenectomy for upper tract urothelial carcinoma

AU - Messer, Jamie

AU - Lin, Yu Kuan

AU - Raman, Jay

PY - 2011/7/1

Y1 - 2011/7/1

N2 - Regional lymphadenectomy, with both its diagnostic and therapeutic roles, serves as an integral component of the management of many malignancies. Extended pelvic lymph node dissection (LND) is the standard of care for urothelial carcinoma of the bladder, with the extent of lymphadenectomy correlating positively with cancer-related outcomes. Given their histologic similarities with bladder cancer, it is reasonable to hypothesize that a similar relationship exists for upper tract urothelial carcinomas (UTUCs). However, the data published to date have failed to consistently demonstrate a therapeutic benefit of regional LND for UTUC. As a consequence, utilization of regional lymphadenectomy remains at the discretion of the surgeon, the extent of LND lacks standardization, and its clinical utility continues to be debated. In order to better clarify the existing data, we present a review of the role of regional lymphadenectomy in patients with UTUC.

AB - Regional lymphadenectomy, with both its diagnostic and therapeutic roles, serves as an integral component of the management of many malignancies. Extended pelvic lymph node dissection (LND) is the standard of care for urothelial carcinoma of the bladder, with the extent of lymphadenectomy correlating positively with cancer-related outcomes. Given their histologic similarities with bladder cancer, it is reasonable to hypothesize that a similar relationship exists for upper tract urothelial carcinomas (UTUCs). However, the data published to date have failed to consistently demonstrate a therapeutic benefit of regional LND for UTUC. As a consequence, utilization of regional lymphadenectomy remains at the discretion of the surgeon, the extent of LND lacks standardization, and its clinical utility continues to be debated. In order to better clarify the existing data, we present a review of the role of regional lymphadenectomy in patients with UTUC.

UR - http://www.scopus.com/inward/record.url?scp=79960211890&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79960211890&partnerID=8YFLogxK

U2 - 10.1038/nrurol.2011.78

DO - 10.1038/nrurol.2011.78

M3 - Review article

C2 - 21606972

AN - SCOPUS:79960211890

VL - 8

SP - 394

EP - 401

JO - Nature Reviews Urology

JF - Nature Reviews Urology

SN - 1759-4812

IS - 7

ER -